<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Neurosciences</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D353BA4A-E082-4536-9091-2CE1BB44DC0F"><gtr:id>D353BA4A-E082-4536-9091-2CE1BB44DC0F</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Jezzard</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802179"><gtr:id>31091557-84F9-42BA-A2BB-2D4279F0A13E</gtr:id><gtr:title>Development of Cerebral Blood Flow and Cerebral Blood Volume Quantification Procedures using MRI without Contrast Agents</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802179</gtr:grantReference><gtr:abstractText>Modern medical imaging methods have transformed the diagnosis and treatment of a number of diseases. To date, most imaging has been used to show only the location of disease in organs such as the brain, helping doctors make diagnoses that include cancer or stroke. Recently a number of techniques have been developed that are able to provide additional information on the brain, such as the amount of blood supplying the tissue, or the density of blood vessels in different parts of the brain. As well as being useful in hospitals, these techniques are also being used by drug companies to provide better information on whether their new drugs are working well. However, many of these newer imaging techniques involve invasive procedures, such as injections, or involve exposing the patient to ionizing radiation. We wish to develop new totally non-invasive techniques using magnetic resonance imaging (MRI) that will be able to make accurate and absolute measurements of blood flow and vessel density in the brain. After verifying the accuracy of these measurements against more established invasive techniques, we will then use them to determine how useful they are in detecting changes caused by introducing a drug into the body. We will also use the new techniques to assess their ability to detect abnormal patterns in patients whose arteries that feed their brain have become partially blocked. If successful, these techniques could then find wider application in the more rapid development of new drugs to treat disease, and in the diagnosis and treatment of a number of brain diseases.</gtr:abstractText><gtr:technicalSummary>Imaging methods that are able to report on tissue function, in addition to structure/pathology, are becoming increasingly important in clinical research and in the pharmaceutical development process. Magnetic resonance imaging is a particularly prominent example of a non-invasive, or minimally invasive, tool for studying neurophysiology, due to its great versatility. However, there is still a need to develop MRI methods for measuring neurophysiological parameters that are truly quantitative and non-invasive. This proposal sets out to develop new quantitative MRI methods for measuring cerebral blood flow (CBF) and cerebral blood volume (CBV). Both these parameters are important in a number of neuropsychiatric disorders, and are also of great utility when assessing the effects of pharmacological intervention. We will use the requirement for signal averaging in the current class of non-invasive CBF and CBV methods to provide an opportunity to optimize the scan parameters in a subject-by-subject manner. This is accomplished by analyzing the data in real time as it is acquired by the MRI scanner. In a collaboration with industry we will validate the robustness of our approach against the gold standard method of positron emission tomography and will also test for reproducibility of the measurements. The methods will then be applied to measure CBF and CBV changes associated with a pharmacological intervention, and will also be tested in a clinical population suffering from cerebrovascular disease. Once validated and demonstrated, these techniques will provide vital new tools to study resting neurophysiology and its modulation following pharmacological intervention of disease.</gtr:technicalSummary><gtr:fund><gtr:end>2013-09-07</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-09-08</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>366103</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir Peter Mansfield Magnetic Resonance Centre</gtr:department><gtr:description>UK 7 Tesla Network</gtr:description><gtr:id>FECDD468-3533-401E-BCDA-2D5E71DDF4CB</gtr:id><gtr:impact>None yet (only just started)</gtr:impact><gtr:outcomeId>56d6e588003914.65329398-1</gtr:outcomeId><gtr:partnerContribution>Likewise</gtr:partnerContribution><gtr:piContribution>7 Tesla protocol and pulse programming expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Opening of the Oxford Acute Vascular Imaging Centre</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C8AAE627-A4DC-4CBD-9CEF-68887DCC73A3</gtr:id><gtr:impact>100 scientists, funding body professionals and healthcare policy makers attended the official opening of the Oxford Acute Vascular Imaging Centre. This consisted of a tour of the facility and a series of keynote lectures. The Oxford AVIC facility focuses on imaging research in patients with acute vascular syndromes.

Very complimentary feedback from all involved, and a number of potential new collaborations proposed by visiting scientists as a result of their visit.</gtr:impact><gtr:outcomeId>Hdp2wGW9dfk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Several presentations to alumni of University and College</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DFE9CA2B-ACDD-4ADD-90A5-F3C426F69B0A</gtr:id><gtr:impact>Several presentations of work at alumni events held across the University and College.

Interest in participation as a human volunteer in the studies, and potential interest in donating money.</gtr:impact><gtr:outcomeId>D534D5488C6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008,2009,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A8952E65-E9A2-4101-82D6-6780573A73E4</gtr:id><gtr:impact>Approx. 50 attendees at a university public outreach event.

Several people asked for further information to be sent to them.</gtr:impact><gtr:outcomeId>Bcvw6JcU22e</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wiltshire County WI</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>16A8592C-E705-4051-9870-4C12177D8CAB</gtr:id><gtr:impact>At their request, 14 members of the Wiltshire WI attended a &amp;quot;scientific outreach&amp;quot; event at the FMRIB Centre, learning about the research we do.

The WI wrote up an article in their regional newsletter that was distributed to all WI members in Wiltshire.</gtr:impact><gtr:outcomeId>oj3WsXeWtNo</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>London International Youth Science Forum</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F9546D8F-0448-4144-AE46-E80AF00E1702</gtr:id><gtr:impact>Four groups of 15 students attended a talk and practical imaging demonstration. Details at www.liysf.org.uk

Several students expressed an interest in studying in a medical imaging related field for their future medical or scientific training.</gtr:impact><gtr:outcomeId>HiJuuSaC67t</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at local 6th Form College</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5E4C4836-B9A7-49E8-B8EB-8D9C4043F466</gtr:id><gtr:impact>Talk to the Year 12 and 13 Science Club at Cherwell School on the principles and applications of Magnetic Resonance Imaging.</gtr:impact><gtr:outcomeId>5808bca8dd5533.34081678</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Siemens Healthcare Advisory Committee</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CEF0653D-31D5-470B-B2AE-FD758CA45E8A</gtr:id><gtr:impact>Siemens Healthcare invited PJ to attend an internal strategy meeting of 12 international experts in the field to discuss the future role of arterial spin labelling in their MRI scanners. The ultimate audience was the Product Definition Group of Siemens Healthcare, who determine what products they wish to take forward.

The work that we are doing on real-time feedback ASL was identified by the panel as a top priority for future development so that it could eventually be translated as a clinical product on commercial MRI scanners.</gtr:impact><gtr:outcomeId>R43Ag5Gbvsx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>5000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK/EPSRC Cancer Imaging Centre (named investigator)</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>ED372840-1DCA-4D8B-A3C7-B8C0C583EFAD</gtr:id><gtr:outcomeId>F773E68C1AD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK 7 Tesla Network Grant</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/N008537/1</gtr:fundingRef><gtr:id>C2BCA93E-AE1F-4FDF-A970-0FD6A0D914AE</gtr:id><gtr:outcomeId>56d6eb250ef243.72721088</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3864276</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centres for Doctoral Training</gtr:description><gtr:end>2022-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/L016052/1</gtr:fundingRef><gtr:id>EAB2A081-7FA4-41E2-A4D0-15C933E56836</gtr:id><gtr:outcomeId>545a5d20403d85.83755063</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8922000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust/MRC/DoH etc. Clinical Research Facility (co-PI)</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>6D4EFF1E-E7CB-4B3B-983F-4CDAD5F9130E</gtr:id><gtr:outcomeId>EDE20F46E2A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed a new method of human blood flow measurement using MRI that is better tailored to individual measurements, and to making an accurate measurement in pathological situations (e.g. cerebrovascular disease)</gtr:description><gtr:id>7228CEDB-478B-43F5-A0E5-445F9E55BAC9</gtr:id><gtr:impact>We plan to use this technique in studying patient populations, and are are about to collaborate with the Juelich Forschungszentrum where they have a combined PET and MRI scanner. They will benefit from our pulse sequence code and we will benefit from access to their PET technology.</gtr:impact><gtr:outcomeId>GyRAon6a599</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Novel MRI pulse sequence for CBF measurement</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4F17F5FD-9ADE-48F5-B9B2-56D450DA0E7E</gtr:id><gtr:title>Vessel-encoded dynamic magnetic resonance angiography using arterial spin labeling.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f881f6c91457a3f0c25e1da441f4c499"><gtr:id>f881f6c91457a3f0c25e1da441f4c499</gtr:id><gtr:otherNames>Okell TW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>mJPaAbHVWv1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D9798AD-C26B-4E85-8F4B-CFC0502199A0</gtr:id><gtr:title>Real-time adaptive sequential design for optimal acquisition of arterial spin labeling MRI data.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fea6ec6cc1da7cdd03a47d7186ab7685"><gtr:id>fea6ec6cc1da7cdd03a47d7186ab7685</gtr:id><gtr:otherNames>Xie J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>Kghqy4YtkS5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88CD02C7-E76F-4E4E-9307-426003C85018</gtr:id><gtr:title>Intracranial hemodynamics is altered by carotid artery disease and after endarterectomy: a dynamic magnetic resonance angiography study.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeeb5792a9837fd285a284a40b57692e"><gtr:id>aeeb5792a9837fd285a284a40b57692e</gtr:id><gtr:otherNames>MacIntosh BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>pm_15623_23_21350206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1F4517D-6F08-4E84-AF8C-76582C6A49E1</gtr:id><gtr:title>A general framework for the analysis of vessel encoded arterial spin labeling for vascular territory mapping.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c71daeb2d4351f348d558a2347179a05"><gtr:id>c71daeb2d4351f348d558a2347179a05</gtr:id><gtr:otherNames>Chappell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>qAN7zkMj2Z5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA69C4A2-440A-407C-B0F2-92E54A2CC246</gtr:id><gtr:title>Hemodynamic alterations in vertebrobasilar large artery disease assessed by arterial spin-labeling MR imaging.</gtr:title><gtr:parentPublicationTitle>AJNR. American journal of neuroradiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cf4260410d551e0b81fbd5edec33da9"><gtr:id>1cf4260410d551e0b81fbd5edec33da9</gtr:id><gtr:otherNames>Macintosh BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0195-6108</gtr:issn><gtr:outcomeId>pm_15623_23_22555580</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEC63DAF-6D8D-4CB5-91DD-946E07FA8F70</gtr:id><gtr:title>Investigating white matter perfusion using optimal sampling strategy arterial spin labeling at 7 Tesla.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88af9d6350a4f22689b33aa830a94d71"><gtr:id>88af9d6350a4f22689b33aa830a94d71</gtr:id><gtr:otherNames>Gardener AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>545a5adf203ef6.63251033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C27FD30-9E3F-4F73-A743-CBB14FBBD79C</gtr:id><gtr:title>Partial volume correction of multiple inversion time arterial spin labeling MRI data.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c71daeb2d4351f348d558a2347179a05"><gtr:id>c71daeb2d4351f348d558a2347179a05</gtr:id><gtr:otherNames>Chappell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>mzPAZCJYffT</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802179</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>